Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Biobot Analytics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Biobot Analytics

Biobot Analytics

Biobot Analytics: Transforming sewers into health observatories with analytics for better cities.

HQ
Cambridge, MA, US
Founded
2017
Accelerator
Y Combinator logoY CombinatorW18
Overview
Compare
Fundraising
Employees
Website

Biobot Analytics, founded with the mission to transform sewers into public health observatories, leverages cutting-edge technology to analyze wastewater for valuable health data. Their core vision is to harness wastewater intelligence to provide early warnings of population health threats and optimize healthcare resources. Biobot's primary product measures opioids and other drug metabolites in sewage to estimate drug consumption in cities, aiding harm reduction efforts and resource allocation.

Notable affiliated individuals include Mariana Matus, co-founder and CEO, and Newsha Ghaeli, co-founder and President. Biobot has attracted significant attention from investors such as Y Combinator. Key achievements include pioneering the use of wastewater data to monitor public health trends and contributing valuable insights during the COVID-19 pandemic. Overall, Biobot Analytics has made a substantial impact by providing innovative tools for public health surveillance and resource optimization.

Biobot Analytics - Similar Companies

Biota Technology logo

Biota Technology

biota.com

Endpoint Health logo

Endpoint Health

Biome Analytics logo

Biome Analytics

biome.io

Owkin logo

Owkin

owkin.com

BioticsAI logo

BioticsAI

biotics.ai

PipeBio logo

PipeBio

Biofourmis logo

Biofourmis

biofourmis.com

biospatial logo

biospatial

biospatial.io

Unstatiq logo

Unstatiq

unstatiq.com

Andson Biotech logo

Andson Biotech

andsonbiotech.com

Orbiter logo

Orbiter

Sepsis Scout logo

Sepsis Scout

Maia Analytica logo

Maia Analytica

maiaanalytica.com

BrilliantBiome logo

BrilliantBiome

brilliantbiome.com

Biotia logo

Biotia

biotia.io

Biobot Analytics - Quick Facts

Who are Biobot Analytics' competitors?

Companies similar to Biobot Analytics include Biota Technology, Endpoint Health, Biome Analytics and Owkin.

When was Biobot Analytics founded?

Biobot Analytics was founded in 2017.

Where is Biobot Analytics' headquarters located?

Biobot Analytics' headquarters is located in Cambridge, MA, US.

How much has Biobot Analytics raised to-date?

As of Sep 21, 2023, Biobot Analytics has raised a total of $28M (USD).

How many employees does Biobot Analytics have?

Biobot Analytics has 104 employees as of Feb 5, 2024.

Biobot Analytics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Wastewater Analytics
Tags
  • Data
  • Healthtech
NAICS
  • 518000Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
  • 518200Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
  • 510000Information
  • 518210Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 3 more industry codes
NAICS
  • 513200Software Publishers
  • 513000Publishing Industries
  • 513210Software Publishers